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Carl-Fredrik Flach1, Fredrik Boulund2, Erik Kristiansson2 and DG Joakim Larsson1*Abstract
Background: The quinolone resistance (qnr) genes are widely distributed among bacteria. We recently developed
and applied probabilistic models to identify tentative novel qnr genes in large public collections of DNA sequence
data including fragmented metagenomes.
Findings: By using inducible recombinant expressions systems the functionality of four identified qnr candidates
were evaluated in Escherichia coli. Expression of several known qnr genes as well as two novel candidates provided
fluoroquinolone resistance that increased with elevated inducer concentrations. The two novel, functionally verified
qnr genes are termed Vfuqnr and assembled qnr 1. Co-expression of two qnr genes suggested non-synergistic action.
Conclusion: The combination of a computational model and recombinant expression systems provides opportunities
to explore and identify novel antibiotic resistance genes in both genomic and metagenomic datasets.
Keywords: qnr, Vfuqnr, assembled qnr 1, Functional verification, Recombinant expression, E. coliFindings
Expression of qnr genes protects type II topoisomerases
from quinolone inhibition, and facilitates the selection of
mutants with higher level of resistance [1,2]. Six families of
plasmid-borne qnr genes have been identified; qnrA, B, C,
D, S and VC [1,3-7]. In addition, chromosomal qnr alleles
have been found in several bacterial species, alleles that may
serve as progenitors of plasmid-borne qnr genes [8-10].
Identifications of the first representative of each qnr
family relied on screening of clinical isolates and resist-
ance transfer assays [1,3-5,7,11], whereas subsequent
studies have identified related qnr genes mainly by using
PCR-based strategies [5,9,10,12]. Lately, several qnr
genes have been discovered based on sequence hom-
ology by use of alignment tools [11,13]. However, this
approach does not efficiently take into account the con-
served pentapeptide repeat pattern of qnr genes, neither
is it suitable for identifying qnr genes in short-read
metagenomic datasets. The lack of optimized methods
suggests that there very well could be many qnr genes
waiting to be discovered. We have recently developed a
computational method based on probabilistic Hidden* Correspondence: joakim.larsson@fysiologi.gu.se
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stated.Markov models with a potential to overcome these hur-
dles. By using this method a number of putative qnr
genes were identified from a large collection of genomes
and metagenomes [14].
In this study we have experimentally evaluated four of
these novel candidates (NC), nc1 – nc4 (Additional file 1),
in recombinant Escherichia coli expression systems, an
approach that has been used with success to characterize
qnr genes previously [3-5,7,8,13,15]. The candidates and
the first members of the six described families of mobile
qnr genes were synthesized (Eurofins MWG Operon,
Ebersberg, Germany) and subcloned into two expression
vectors, pZE21 and pZA14 (Expressys, Ruelzheim,
Germany), under the control of two different inducible
promoters, PLtetO-1 and Plac/ara-1 respectively. The vectors
carry either the ColE1 (pZE21) or the p15A (pZA14) origin
of replication, and thus belong to different plasmid com-
patibility groups [16]. Although several cloning procedures
were tested, both by us and a contract lab, nc4 could not
be subcloned into the pZA14 vector and was thus not eval-
uated under the control of the Plac/ara-1 promoter. However,
this was not likely due to toxicity of the gene product, as
has been reported for EfsQnr previously [17], since nc4
could be evaluated in the E. coli host using the pZE21
vector. The recombinant plasmids were electroporated into
E. coli C600Z1 (Expressys), which expresses repressors fortd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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kinds of expression systems allow the evaluation of gene
candidates without knowledge of the intrinsic promoter,
information that is often difficult to capture when genes are
reconstructed from fragmented metagenomes. In addition,
the approach does not depend on the functionality of an
intrinsic promoter in a heterologous expression host.
In order to investigate the genes’ capacity to confer
fluoroquinolone resistance to the E. coli host, different con-
centrations of expression inducers were added to the
Mueller-Hinton growth media used for fluoroquinolone
susceptibility determinations with Etest® gradient strips
(BioMérieux SA, Marcy l’Etoile, France). When the genes
were evaluated under the control of the anhydrotetracycline
(aTc)-inducible promoter PLtetO-1, all strains carrying known
qnr genes showed ciprofloxacin minimal inhibitory concen-
trations (MICs) that increased with elevated inducer con-
centration (Figure 1A). In addition, strains carrying the
novel qnr candidates nc2 and nc4 showed similar changes
in ciprofloxacin susceptibility. All genes providing increased
ciprofloxacin MICs after addition of aTc also conferred re-
sistance when evaluated in the recombinant expression sys-
tem controlled by the IPTG and arabinose-induced Plac/ara-1
promoter (Figure 1B). In the latter system a marginal MIC
increase was observed also for nc1 and nc3 after addition of
inducer, however a similar small increase was also observed
for the control carrying the non-related luciferase gene in-
stead of any qnr gene. Noteworthy, the choice of inducible
promoter determined which qnr genes that gave rise to the
strongest resistance phenotype, confirming the importance
of genetic context. Comparable results were obtained
when moxifloxacin susceptibility was evaluated after in-
duced expression of the four candidates, nc2 and nc4 be-
ing the two that conferred fluoroquinolone resistance to
the host (Additional file 2).
Although recombinant expression in E. coli could not
verify nc1 and nc3 as functional qnr genes, it does not rule
out functionality in another host. The nc1 is relatively dis-
similar to all known qnr genes (33% amino acid identity toA
Figure 1 Ciprofloxacin MICs for recombinant E. coli strains carrying kn
genes are situated on pZE21 (A) or pZA14 (B), and expression was stimula
IPTG/Arabinose (B).QnrC and QnrS1) and originates from a coastal sea water
metagenome, suggesting that the natural bacterial host
might be distantly related to E. coli. The nc2 gene was
identified in the sequenced genome of Vibrio furnissii [18]
and its deduced protein product shows 72% identity to
QnrC and QnrVC1 (Figure 2). When the nc4 gene was
identified in baby stool metagenomes, its gene product
showed the highest similarity to QnrB determinants iden-
tified in Citrobacter freundii (up to 80% identity) [9]. Later,
sequences from Serratia marcescens encoding a protein,
not verified to confer resistance, showing 98% identity
with NC4 have been submitted to GenBank [19]. Only
three amino acids between position 142 and 146 differ be-
tween NC3 and NC4. Our results indicate that this region
is of importance for the protein’s functionality, at least in
E.coli. The two candidates show 78-79% identity to QnrB1
(Figure 2), for which two loop structures are important for
the quinolone inhibiting action [20]. In addition,
mutational analyses of QnrB1 have identified several indi-
vidual amino acids critical for its protective activity
[21,22]. However, amino acids 142–146 are not located
within the loop structures and were not included or iden-
tified as critical in the mutational analyses.
Various bacteria, including E. coli, may carry two
different qnr genes [24,25]. The benefit of this is not known.
We therefore constructed recombinant strains containing
two qnr genes situated on different plasmids (pZE21 and
pZA14). We evaluated six different combinations of qnr
genes including qnrS together with either qnrA or qnrB,
which are two of the combinations observed in clinical
isolates [24,25]. After induction with three different concen-
trations of inducers, at the most, a marginal increase in cip-
rofloxacin MIC (less than two-fold) was observed when
both qnr genes were induced (Figure 3). This suggests a
non-synergistic effect, which is in line with the assumed
mode of action of Qnr proteins as well as with earlier
susceptibility determinations showing that isolates carrying
two qnr genes do not display a superior resistance pheno-
type [24,25].B
own qnr genes or novel candidates (nc1-4). The investigated
ted by adding indicated concentrations of the inducers aTc (A) or
Figure 2 Phylogenetic tree showing the relationships between Qnr variants. The six plasmid-borne classes are shown in bold. The two
candidates functionally verified in this work are marked with an asterisk (NC2 and NC4). The tree was constructed using MrBayes [23].
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verified qnr genes nc2 and nc4, which provide resistance to
the E.coli host at the same level as previously reported qnr
genes, should be termed Vfuqnr and assembled qnr 1, re-
spectively (Figure 2). The name Vfuqnr reflects the host ofFigure 3 Ciprofloxacin susceptibility of recombinant E. coli strains car
determined after addition of inducers at three different concentrations des
plasmid (blue bars), the pZA14 plasmid (green bars), or both (striped bars).
and from which plasmids they are expressed.the gene, whereas the latter name is chosen to reflect that
the gene is assembled from metagenomic DNA, and that
the host is not known. The nucleotide sequences of Vfuqnr
and assembled qnr 1 have been submitted to GenBank
(accession number BK008765 and KF278752, respectively).rying two different qnr genes. MICs of ciprofloxacin were
cribed in Figure 1, which stimulated expression from the pZE21
The header of each graph describes the qnr content of each strain
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quinolone resistance genes. The development of a prob-
abilistic Hidden Markov model and inducible recombin-
ant expression systems together provided an efficient
approach for exploring bacterial genomes and fragmen-
ted metagenomic datasets for the presence of novel qnr
genes. We propose that a similar concept could be de-
veloped and used to identify resistance genes for other
classes of antibiotics as well.
Availability of supporting data
The data sets supporting the results of this article are
included within the article and its additional files.
Additional files
Additional file 1: Table S1. Nucleotide sequences of the novel candidate
(nc) genes.
Additional file 2: Figure S1. Moxifloxacin MICs for recombinant E. coli
strains carrying known qnr genes or novel candidates (nc1‐4). The investigated
genes are situated on pZE21 (A) or pZA14 (B), and expression was stimulated by
adding indicated concentrations of the inducers aTc (A) or IPTG/Arabinose (B).
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CFF designed and performed the cloning and antibiotic susceptibility
determination experiments as well as drafted the manuscript. FB performed
the bioinformatic analyses and revised the manuscript. DGJL and EK
conceived the study and revised the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
This work was supported by the Swedish Research Council, Formas, MISTRA,
the Adlerbert Research Foundation, and the Life Science Area of Advance at
Chalmers University of Technology.
Author details
1Department of Infectious Diseases, University of Gothenburg, Gothenburg,
Sweden. 2Department of Mathematical Statistics, Chalmers University of
Technology, Gothenburg, Sweden.
Received: 10 September 2013 Accepted: 14 November 2013
Published: 21 November 2013
References
1. Martinez-Martinez L, Pascual A, Jacoby GA: Quinolone resistance from a
transferable plasmid. Lancet 1998, 351(9105):797–799.
2. Tran JH, Jacoby GA: Mechanism of plasmid-mediated quinolone
resistance. Proc Natl Acad Sci USA 2002, 99(8):5638–5642.
3. Cavaco LM, Hasman H, Xia S, Aarestrup FM: qnrD, a novel gene conferring
transferable quinolone resistance in Salmonella enterica serovar
Kentucky and Bovismorbificans strains of human origin. Antimicrob
Agents Chemother 2009, 53(2):603–608.
4. Hata M, Suzuki M, Matsumoto M, Takahashi M, Sato K, Ibe S, Sakae K:
Cloning of a novel gene for quinolone resistance from a transferable
plasmid in Shigella flexneri 2b. Antimicrob Agents Chemother 2005,
49(2):801–803.
5. Jacoby GA, Walsh KE, Mills DM, Walker VJ, Oh H, Robicsek A, Hooper DC:
qnrB, another plasmid-mediated gene for quinolone resistance.
Antimicrob Agents Chemother 2006, 50(4):1178–1182.
6. Pons MJ, Gomes C, Ruiz J: QnrVC, a new transferable Qnr-like family.
Enferm Infecc Microbiol Clin 2013, 31(3):191–192.7. Wang M, Guo Q, Xu X, Wang X, Ye X, Wu S, Hooper DC: New plasmid-mediated
quinolone resistance gene, qnrC, found in a clinical isolate of Proteus
mirabilis. Antimicrob Agents Chemother 2009, 53(5):1892–1897.
8. Cattoir V, Poirel L, Mazel D, Soussy CJ, Nordmann P: Vibrio splendidus as
the source of plasmid-mediated QnrS-like quinolone resistance
determinants. Antimicrob Agents Chemother 2007, 51(7):2650–2651.
9. Jacoby GA, Griffin CM, Hooper DC: Citrobacter spp. as a source of qnrB
Alleles. Antimicrob Agents Chemother 2011, 55(11):4979–4984.
10. Poirel L, Rodriguez-Martinez JM, Mammeri H, Liard A, Nordmann P: Origin
of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob
Agents Chemother 2005, 49(8):3523–3525.
11. Fonseca EL, Dos Santos FF, Vieira VV, Vicente AC: New qnr gene cassettes
associated with superintegron repeats in Vibrio cholerae O1. Emerg Infect
Dis 2008, 14(7):1129–1131.
12. Guillard T, de Champs C, Moret H, Bertrand X, Scheftel JM, Cambau E:
High-resolution melting analysis for rapid characterization of qnr alleles
in clinical isolates and detection of two novel alleles, qnrB25 and
qnrB42. J Antimicrob Chemother 2012, 67(11):2635–2639.
13. Sanchez MB, Hernandez A, Rodriguez-Martinez JM, Martinez-Martinez L,
Martinez JL: Predictive analysis of transmissible quinolone resistance
indicates Stenotrophomonas maltophilia as a potential source of a novel
family of Qnr determinants. BMC Microbiol 2008, 8:148.
14. Boulund F, Johnning A, Pereira MB, Larsson DGJ, Kristiansson E: A novel
method to discover fluoroquinolone antibiotic resistance (qnr) genes in
fragmented nucleotide sequences. BMC Genomics 2012, 13:695.
15. Rodriguez-Martinez JM, Velasco C, Briales A, Garcia I, Conejo MC, Pascual A:
Qnr-like pentapeptide repeat proteins in gram-positive bacteria.
J Antimicrob Chemother 2008, 61(6):1240–1243.
16. Lutz R, Bujard H: Independent and tight regulation of transcriptional
units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2
regulatory elements. Nucleic Acids Res 1997, 25(6):1203–1210.
17. Hegde SS, Vetting MW, Mitchenall LA, Maxwell A, Blanchard JS: Structural
and biochemical analysis of the pentapeptide repeat protein EfsQnr, a
potent DNA gyrase inhibitor. Antimicrob Agents Chemother 2011,
55(1):110–117.
18. Lux TM, Lee R, Love J: Complete genome sequence of a free-living Vibrio
furnissii sp. nov. strain (NCTC 11218). J Bacteriol 2011, 193(6):1487–1488.
19. Kuo PA, Kuo CH, Lai YK, Graumann PL, Tu J: Phosphate limitation induces
the intergeneric inhibition of Pseudomonas aeruginosa by Serratia
marcescens isolated from paper machines. FEMS Microbiol Ecol 2013,
84(3):577–587.
20. Vetting MW, Hegde SS, Wang M, Jacoby GA, Hooper DC, Blanchard JS:
Structure of QnrB1, a plasmid-mediated fluoroquinolone resistance
factor. J Biol Chem 2011, 286(28):25265–25273.
21. Rodriguez-Martinez JM, Briales A, Velasco C, Conejo MC, Martinez-Martinez
L, Pascual A: Mutational analysis of quinolone resistance in the
plasmid-encoded pentapeptide repeat proteins QnrA. QnrB and QnrS J
Antimicrob Chemother 2009, 63(6):1128–1134.
22. Jacoby GA, Corcoran MA, Mills DM, Griffin CM, Hooper DC: Mutational
analysis of the Quinolone resistance protein QnrB1. Antimicrob Agents
Chemother 2013, 57(11):5733–5736.
23. Ronquist F, Huelsenbeck JP: MrBayes 3: Bayesian phylogenetic inference
under mixed models. Bioinformatics 2003, 19(12):1572–1574.
24. Le TM, Baker S, Le TP, Cao TT, Tran TT, Nguyen VM, Campbell JI, Lam MY,
Nguyen TH, Nguyen VV, Farrar J, Schultsz C: High prevalence of
plasmid-mediated quinolone resistance determinants in commensal
members of the Enterobacteriaceae in Ho Chi Minh City. Vietnam J Med
Microbiol 2009, 58(Pt 12):1585–1592.
25. Zhou TL, Chen XJ, Zhou MM, Zhao YJ, Luo XH, Bao QY: Prevalence of
plasmid-mediated quinolone resistance in Escherichia coli isolates in
Wenzhou, Southern China, 2002–2008. Jpn J Infect Dis 2011, 64(1):55–57.
doi:10.1186/1476-0711-12-34
Cite this article as: Flach et al.: Functional verification of
computationally predicted qnr genes. Annals of Clinical Microbiology and
Antimicrobials 2013 12:34.
